Clinical Evaluation of an Integrated PET/MRI System
Not Applicable
Completed
- Conditions
- Subjects With Clinical Indication for PET/CT
- Registration Number
- NCT02071706
- Lead Sponsor
- GE Healthcare
- Brief Summary
The investigational PET/MRI scanner, including attenuation correction method, is capable of producing diagnostic quality images and appropriate device functionality per user feedback.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 62
Inclusion Criteria
- Subject must have a clinical indication for a PET/CT exam
- Subject must be at least eighteen (18) years of age; and
- Female subjects that are determined to be non-pregnant by a physician investigator or are demonstrated non-pregnant by negative urine pregnancy test administered within the 24 hour period before PET/CT imaging; and
- Subject must be able to hear and understand instructions without assistive devices; and
- Subject must provide written informed consent; and
- Subject has the necessary mental capacity to understand instructions, and is able to comply with protocol requirements; and
- Subject is able to remain still for duration of imaging procedure (approximately 60 minutes total for PET/MRI); and
- Subject must be able to participate in a PET/MR imaging session within 2 hours of concluding their PET/CT exam and within 4 hours of PET radiotracer administration.
Exclusion Criteria
- Subjects who have any axial diameter larger than 55 cm; or
- Subjects with a weight greater than 227 kgs; or
- Subjects that have metallic/conductive or electrically/magnetically active implants without MR Safe or MR Conditional labeling, with the exception of dental devices/fillings, surgical clips, and surgical staples determined to be safe for MRI scanning by a physician investigator; or
- Subjects that have implants with MR Unsafe labeling; or
- Subjects that have implants labeled as MR Conditional by the manufacturer for which the allowable conditions are not expected to be achieved by the MR/PET environment or scan protocol ; or
- Subjects who have a contraindication to MRI according to the screening policy of the participating site
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Number Usable PET/MRI Image Sets 1 day The number PET/MRI image sets determined usable by a radiologist on a yes/no binary scale
Number of Diagnostic Quality Images 1 day Number of images sets deemed diagnostic quality by the investigator
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of PET/MRI in diagnosing cancer compared to PET/CT?
How does PET/MRI compare to standard-of-care imaging in detecting tumor biomarkers?
What are the key biomarkers for patient selection in PET/MRI clinical trials?
What adverse events are associated with integrated PET/MRI systems in oncology?
What are the competitive imaging technologies to GE Healthcare's PET/MRI system in 2014?
Trial Locations
- Locations (1)
UniversitätsSpital Zürich
🇨🇭Zurich, Switzerland
UniversitätsSpital Zürich🇨🇭Zurich, Switzerland